5- HTP
Natural health product licensed in Canada
- Licence holder
- Nutri-Dyn Products Ltd. DBA Professional Health Products
- NPN or DIN-HM
- 80007799
- Status
- Inactive licence
- Licence date
- 25 September 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
| Adultes | Not specified | 3 Capsule | 3 Tous les jours |
| Adultes | Not specified | 1 Capsule | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Helps to promote healthy mood balance. Helps relieve symptoms of fibromyalgia. Helps to reduce the severity and duration of migraine headaches when taken as a prophylactic. To be used with a program of reduced intake of diatary calories and increased physical activity (if possible), to help in weight management by reducing carbohydrate cravings. Used as a sleep aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner in the following circumstances: if symptoms persist or worsen, if you are pregnant or breastfeeding, if you are taking carbidopa or drugs / supplements with seratonergic activity. These include, but are not limited to, L-Tryptophan, S-AdenosylMethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain, or if you experience skin changes. For use as a sleep aid: consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia).
- Contre-indications
Do not use if you have scleroderma.
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Some people may experience diarrhea, nausea, vomiting and abdominal pain.
Source
Official Health Canada record, licence 80007799
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.